EirGenix provides not just technology services but integral solutions that you can rely on.
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
EirGenix Achieves The Second Milestone Of Its Biosimilar Trastuzumab - Licensing Agreement
EirGenix Receives Approval From Japan's PMDA
EirGenix At Healthcare + Expo Taiwan – December 5-8, 2019
EirGenix at BIO Asia-Taiwan Conference and Exhibition - July 25-28, 2019
Our facility is located in Taiwan, and offers the service to clients around the world.
